Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CYH vs UHS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CYH
Community Health Systems, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$404M
5Y Perf.-8.9%
UHS
Universal Health Services, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$10.55B
5Y Perf.+59.8%

CYH vs UHS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CYH logoCYH
UHS logoUHS
IndustryMedical - Care FacilitiesMedical - Care Facilities
Market Cap$404M$10.55B
Revenue (TTM)$21.48B$17.76B
Net Income (TTM)$-88M$1.52B
Gross Margin53.7%67.6%
Operating Margin-39.8%11.5%
Forward P/E0.8x7.2x
Total Debt$11.58B$5.51B
Cash & Equiv.$260M$138M

CYH vs UHSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CYH
UHS
StockMay 20May 26Return
Community Health Sy… (CYH)10091.1-8.9%
Universal Health Se… (UHS)100159.8+59.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: CYH vs UHS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UHS leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Community Health Systems, Inc. is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
CYH
Community Health Systems, Inc.
The Income Pick

CYH is the clearest fit if your priority is income & stability.

  • Dividend streak 2 yrs, beta 1.60
  • Lower P/E (0.8x vs 7.2x)
  • -1.0% vs UHS's -8.1%
Best for: income & stability
UHS
Universal Health Services, Inc.
The Growth Play

UHS carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 9.7%, EPS growth 37.3%, 3Y rev CAGR 9.0%
  • 30.4% 10Y total return vs CYH's -80.7%
  • Lower volatility, beta 0.60, Low D/E 74.3%, current ratio 1.05x
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthUHS logoUHS9.7% revenue growth vs CYH's -1.2%
ValueCYH logoCYHLower P/E (0.8x vs 7.2x)
Quality / MarginsUHS logoUHS8.6% margin vs CYH's -0.4%
Stability / SafetyUHS logoUHSBeta 0.60 vs CYH's 1.60
DividendsUHS logoUHS0.5% yield; 1-year raise streak; the other pay no meaningful dividend
Momentum (1Y)CYH logoCYH-1.0% vs UHS's -8.1%
Efficiency (ROA)UHS logoUHS9.8% ROA vs CYH's -0.7%, ROIC 12.3% vs -70.1%

CYH vs UHS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CYHCommunity Health Systems, Inc.
FY 2025
Managed Care And Other Third Party Payors
58.4%$6.0B
Medicare
21.2%$2.2B
Medicaid
19.5%$2.0B
Self Pay Revenue
0.9%$96M
UHSUniversal Health Services, Inc.
FY 2025
Acute Care Hospital Services
57.2%$9.9B
Behavioral Health Services
42.8%$7.4B

CYH vs UHS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUHSLAGGINGCYH

Income & Cash Flow (Last 12 Months)

UHS leads this category, winning 5 of 6 comparable metrics.

CYH and UHS operate at a comparable scale, with $21.5B and $17.8B in trailing revenue. UHS is the more profitable business, keeping 8.6% of every revenue dollar as net income compared to CYH's -0.4%. On growth, CYH holds the edge at +2.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCYH logoCYHCommunity Health …UHS logoUHSUniversal Health …
RevenueTrailing 12 months$21.5B$17.8B
EBITDAEarnings before interest/tax-$7.8B$2.7B
Net IncomeAfter-tax profit-$88M$1.5B
Free Cash FlowCash after capex-$200M$894M
Gross MarginGross profit ÷ Revenue+53.7%+67.6%
Operating MarginEBIT ÷ Revenue-39.8%+11.5%
Net MarginNet income ÷ Revenue-0.4%+8.6%
FCF MarginFCF ÷ Revenue-0.9%+5.0%
Rev. Growth (YoY)Latest quarter vs prior year+2.8%+9.6%
EPS Growth (YoY)Latest quarter vs prior year-45.2%+17.7%
UHS leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

CYH leads this category, winning 3 of 3 comparable metrics.

At 0.8x trailing earnings, CYH trades at a 90% valuation discount to UHS's 7.3x P/E.

MetricCYH logoCYHCommunity Health …UHS logoUHSUniversal Health …
Market CapShares × price$404M$10.5B
Enterprise ValueMkt cap + debt − cash$11.7B$15.9B
Trailing P/EPrice ÷ TTM EPS0.76x7.29x
Forward P/EPrice ÷ next-FY EPS est.7.21x
PEG RatioP/E ÷ EPS growth rate0.46x
EV / EBITDAEnterprise value multiple6.09x
Price / SalesMarket cap ÷ Revenue0.03x0.61x
Price / BookPrice ÷ Book value/share1.47x
Price / FCFMarket cap ÷ FCF1.94x12.42x
CYH leads this category, winning 3 of 3 comparable metrics.

Profitability & Efficiency

UHS leads this category, winning 6 of 6 comparable metrics.
MetricCYH logoCYHCommunity Health …UHS logoUHSUniversal Health …
ROE (TTM)Return on equity+20.7%
ROA (TTM)Return on assets-0.7%+9.8%
ROICReturn on invested capital-70.1%+12.3%
ROCEReturn on capital employed-87.3%+16.0%
Piotroski ScoreFundamental quality 0–966
Debt / EquityFinancial leverage0.74x
Net DebtTotal debt minus cash$11.3B$5.4B
Cash & Equiv.Liquid assets$260M$138M
Total DebtShort + long-term debt$11.6B$5.5B
Interest CoverageEBIT ÷ Interest expense4.89x10.92x
UHS leads this category, winning 6 of 6 comparable metrics.

Total Returns (Dividends Reinvested)

UHS leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in UHS five years ago would be worth $11,165 today (with dividends reinvested), compared to $2,049 for CYH. Over the past 12 months, CYH leads with a -1.0% total return vs UHS's -8.1%. The 3-year compound annual growth rate (CAGR) favors UHS at 6.1% vs CYH's -6.2% — a key indicator of consistent wealth creation.

MetricCYH logoCYHCommunity Health …UHS logoUHSUniversal Health …
YTD ReturnYear-to-date-7.4%-23.3%
1-Year ReturnPast 12 months-1.0%-8.1%
3-Year ReturnCumulative with dividends-17.5%+19.3%
5-Year ReturnCumulative with dividends-79.5%+11.7%
10-Year ReturnCumulative with dividends-80.7%+30.4%
CAGR (3Y)Annualised 3-year return-6.2%+6.1%
UHS leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

UHS leads this category, winning 2 of 2 comparable metrics.

UHS is the less volatile stock with a 0.60 beta — it tends to amplify market swings less than CYH's 1.60 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UHS currently trades 68.4% from its 52-week high vs CYH's 64.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCYH logoCYHCommunity Health …UHS logoUHSUniversal Health …
Beta (5Y)Sensitivity to S&P 5001.60x0.60x
52-Week HighHighest price in past year$4.47$246.33
52-Week LowLowest price in past year$2.38$152.33
% of 52W HighCurrent price vs 52-week peak+64.2%+68.4%
RSI (14)Momentum oscillator 0–10044.035.2
Avg Volume (50D)Average daily shares traded1.6M791K
UHS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

CYH leads this category, winning 1 of 1 comparable metric.

Wall Street rates CYH as "Hold" and UHS as "Hold". Consensus price targets imply 37.4% upside for UHS (target: $232) vs 2.1% for CYH (target: $3). UHS is the only dividend payer here at 0.47% yield — a key consideration for income-focused portfolios.

MetricCYH logoCYHCommunity Health …UHS logoUHSUniversal Health …
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$2.93$231.50
# AnalystsCovering analysts3743
Dividend YieldAnnual dividend ÷ price+0.5%
Dividend StreakConsecutive years of raises21
Dividend / ShareAnnual DPS$0.80
Buyback YieldShare repurchases ÷ mkt cap+0.5%+9.2%
CYH leads this category, winning 1 of 1 comparable metric.
Key Takeaway

UHS leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CYH leads in 2 (Valuation Metrics, Analyst Outlook).

Best OverallUniversal Health Services, … (UHS)Leads 4 of 6 categories
Loading custom metrics...

CYH vs UHS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is CYH or UHS a better buy right now?

For growth investors, Universal Health Services, Inc.

(UHS) is the stronger pick with 9. 7% revenue growth year-over-year, versus -1. 2% for Community Health Systems, Inc. (CYH). Community Health Systems, Inc. (CYH) offers the better valuation at 0. 8x trailing P/E, making it the more compelling value choice. Analysts rate Community Health Systems, Inc. (CYH) a "Hold" — based on 37 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CYH or UHS?

On trailing P/E, Community Health Systems, Inc.

(CYH) is the cheapest at 0. 8x versus Universal Health Services, Inc. at 7. 3x.

03

Which is the better long-term investment — CYH or UHS?

Over the past 5 years, Universal Health Services, Inc.

(UHS) delivered a total return of +11. 7%, compared to -79. 5% for Community Health Systems, Inc. (CYH). Over 10 years, the gap is even starker: UHS returned +30. 4% versus CYH's -80. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CYH or UHS?

By beta (market sensitivity over 5 years), Universal Health Services, Inc.

(UHS) is the lower-risk stock at 0. 60β versus Community Health Systems, Inc. 's 1. 60β — meaning CYH is approximately 166% more volatile than UHS relative to the S&P 500.

05

Which is growing faster — CYH or UHS?

By revenue growth (latest reported year), Universal Health Services, Inc.

(UHS) is pulling ahead at 9. 7% versus -1. 2% for Community Health Systems, Inc. (CYH). On earnings-per-share growth, the picture is similar: Community Health Systems, Inc. grew EPS 196. 7% year-over-year, compared to 37. 3% for Universal Health Services, Inc.. Over a 3-year CAGR, UHS leads at 9. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CYH or UHS?

Universal Health Services, Inc.

(UHS) is the more profitable company, earning 8. 6% net margin versus 4. 1% for Community Health Systems, Inc. — meaning it keeps 8. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UHS leads at 11. 5% versus -79. 4% for CYH. At the gross margin level — before operating expenses — UHS leads at 90. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CYH or UHS more undervalued right now?

Analyst consensus price targets imply the most upside for UHS: 37.

4% to $231. 50.

08

Which pays a better dividend — CYH or UHS?

In this comparison, UHS (0.

5% yield) pays a dividend. CYH does not pay a meaningful dividend and should not be held primarily for income.

09

Is CYH or UHS better for a retirement portfolio?

For long-horizon retirement investors, Universal Health Services, Inc.

(UHS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 60)). Community Health Systems, Inc. (CYH) carries a higher beta of 1. 60 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UHS: +30. 4%, CYH: -80. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CYH and UHS?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CYH

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 142%
  • Gross Margin > 32%
Run This Screen
Stocks Like

UHS

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CYH and UHS on the metrics below

Revenue Growth>
%
(CYH: 284.9% · UHS: 9.6%)
P/E Ratio<
x
(CYH: 0.8x · UHS: 7.3x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.